静脉血栓栓塞的危险因素在急性原肌细胞白血病
Nikica Sabljic1, Nikola Pantic1, Marijana Virijevic1,2
1Clinic of Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Cancers
|January 8, 2025
概括
在急性前列细胞白血病 (APL) 中,较高的CD114表达和没有出血预测静脉血栓栓塞 (VTE). 目前的风险模型不足以通过VTE风险对APL患者进行分层.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 急性肌肉细胞性白血病 (APL) 往往呈现出扩散性血管内凝血 (DIC),主要导致出血并发症.
- 血栓事件虽然比出血不常见,但在APL管理中代表着重大的临床挑战.
研究的目的:
- 为了确定成年APL患者静脉血栓塞栓症 (VTE) 的发生率.
- 评估人口因素,临床-实验室参数和现有的风险评估模型 (RAMs) 在APL中对VTE的预测价值.
- 在这个患者群体中确定VTE的新风险因素.
主要方法:
- 在2006年至2024年期间,对成年APL患者进行了全转网红酸 (ATRA) 和环素治疗的回顾性分析.
- 收集和分析人口统计,临床实验室和VTE相关数据.
- 对 Al-Ani 和 Paterno RAM 对 VTE 的预测性能的评估.
主要成果:
- 在155名APL患者中,VTE发生在18.1%的患者中,其中中央静脉导管 (CVC) 血栓形成最频繁 (42.8%).
- 无论是Al-Ani还是Paterno RAM都没有显示出VTE的预测值 (C统计 ≈0.52).
- 多变量分析确定了CD114表达 (OR=6.4) 和呈现时没有出血 (OR=0.086) 作为独立的VTE风险因素.
结论:
- 这项研究是第一个将更高的CD114表达与APL中增加的VTE风险联系在一起的研究.
- 在呈现时没有出血是APL患者血栓形成的重要相关因子.
- 新的风险因素需要进一步调查,以制定APL有效的VTE预防策略,因为目前的RAM不足.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
9.9K
相关概念视频
Disorders of Leukocytes
846
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
846
Disorders of Hemostasis
696
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
696
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Bone Marrow Sampling and Transplants
279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
